Refractory Anemia [clinicaltrials_resource:a79a18ca54c5cd8124a942e6c447ac36]
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002798]Tipifarnib in Treating Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00005845]Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [clinicaltrials:NCT00012376]Thalidomide in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00015990]Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00027820]Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant [clinicaltrials:NCT00078858]clinicaltrials:NCT00104962Bowel Preparation and Prokinetics in Capsule Endoscopy [clinicaltrials:NCT00275184]clinicaltrials:NCT00309842A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies [clinicaltrials:NCT00343798]Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [clinicaltrials:NCT00392353]Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders [clinicaltrials:NCT00397813]MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia [clinicaltrials:NCT00462605]Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant [clinicaltrials:NCT00796068]clinicaltrials:NCT01012492Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT01146210]clinicaltrials:NCT01165996Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies [clinicaltrials:NCT01175785]clinicaltrials:NCT01273766clinicaltrials:NCT01384513Donor Umbilical Cord Blood Transplant With or Without Ex-Vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes [clinicaltrials:NCT01690520]Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies [clinicaltrials:NCT01789255]
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Refractory Anemia [clinicaltrials_resource:a79a18ca54c5cd8124a942e6c447ac36]
Bio2RDF identifier
a79a18ca54c5cd8124a942e6c447ac36
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a79a18ca54c5cd8124a942e6c447ac36
identifier
clinicaltrials_resource:a79a18ca54c5cd8124a942e6c447ac36
title
Refractory Anemia
@en
label
Refractory Anemia [clinicaltrials_resource:a79a18ca54c5cd8124a942e6c447ac36]
@en